Cue Biopharma (CUE) announced the appointment of Shao-Lee Lin as CEO president and director. Lin will succeed Lucinda Warren, interim president and CEO. Prior to joining Cue, Lin was founder and CEO of Acelyrin.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: